Decreased SPLUNC1 expression is associated with Pseudomonas infection in surgically treated chronic rhinosinusitis patients who may require repeated sinus surgery

Laryngoscope

Volumn 123, Issue 4, 2013, Pages 845-851

  Tsou, Yung An ^a,b,c   Chen, Chuan Mu ^c   Lin, Tzu Chieh ^a   Hu, Fang Wei ^d   Tai, Chin Jann ^a   Chen, Hui Chen ^b   Yeh, Te Huei ^e   Harn, Horng Jyh ^b   Tsai, Ming Hsui ^a,b   Jan, Chia Ing ^b,f  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

biofilm; chronic rhinosinusitis; Pseudomonas aeruginosa; repeated sinus surgery; SPLUNC1

Indexed keywords

BACTERIAL PROTEIN; MESSENGER RNA; SHORT PALATE, LUNG, AND NASAL EPITHELIAL CLONE 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIUM CULTURE; BIOFILM; CHRONIC RHINOSINUSITIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOSCOPIC SINUS SURGERY; FEMALE; FISHERMAN; GENDER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; NOSE MUCOSA; NOSE POLYP; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RECURRENT INFECTION; REOPERATION; RETROSPECTIVE STUDY; SCORING SYSTEM; SIGNAL TRANSDUCTION; STUDENT T TEST; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

CHRONIC DISEASE; GLYCOPROTEINS; HUMANS; PARANASAL SINUSES; PHOSPHOPROTEINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REOPERATION; RETROSPECTIVE STUDIES; RHINITIS; SINUSITIS; TREATMENT OUTCOME;

EID: 84875448980     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23871     Document Type: Article

References (20)

1. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M,. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2006; 134: 991-996.
2. Gakhar L, Bartlett JA, Penterman J, et al. PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One 2010; 5: e9098.
3. Bhattacharyya N, Kepnes LJ,. The microbiology of recurrent rhinosinusitis after endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg 1999; 125: 1117-1120.
4. Bingle L, Cross SS, High AS, et al. SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype. J Pathol 2005; 205: 491-497.
5. Casado B, Pannell LK, Iadarola P, Baraniuk JN,. Identification of human nasal mucous proteins using proteomics. Proteomics 2005; 5: 2949-2959.
6. Lindahl M, Stahlbom B, Tagesson C,. Identification of a new potential airway irritation marker, palate lung nasal epithelial clone protein, in human nasal lavage fluid with two-dimensional electrophoresis and matrix-assisted laser resorption/ionizationtime of flight. Electrophoresis 2001; 22: 1795-1800.
7. Kim CH, Kim K, Jik Kim H, et al. Expression and regulation of PLUNC in human nasal epithelium. Acta Otolaryngol 2006; 126: 1073-1078.
8. Bingle CD, Wilson K, Lunn H, et al. Human LPLUNC1 is a secreted product of goblet cells and minor glands of the respiratory and upper aerodigestive tracts. Histochem Cell Biol 2010; 133: 505-515.
9. Zhou HD, Li XL, Li GY, et al. Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus. Mol Cell Biochem 2008; 309: 191-197.
10. Gross CA, Bowler RP, Green RM, Weinberger AR, Schnell C, Chu HW,. Beta2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells. BMC Pulm Med 2010; 10: 30.
11. Min-man W, Hong S, Zhi-qiang X, et al. Differential proteomic analysis of nasal polyps, chronic sinusitis, and normal nasal mucosa tissues. Otolaryngol Head Neck Surg 2009; 141: 364-368.
12. Lukinskiene L, Liu Y, Reynolds SD, et al. Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection. J Immunol 2011; 187: 382-390.
13. Jan CI, Yu CC, Hung MC, et al. Tid, CHIP, and ErbB2 interactions and their prognostic implications for breast cancer patients. J Pathol 2011; 225: 424-437.
14. McCarty KS Jr, Miller LS, Cox EB, et al. Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal anti receptor antibodies. Arch Pathol Lab Med 1985; 109: 716-721.
15. Gally F, Di YP, Smith SK, et al. SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice. Am J Pathol 2011; 178: 2159-2167.
16. Garcia-Caballero A, Rasmussen JE, Gaillard E, et al. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci U S A 2009; 106: 11412-11417.
17. Knowles MR, Boucher RC,. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002; 109: 571-577.
18. Rossier BC,. The epithelial sodium channel: activation by membrane-bound serine proteases. Proc Am Thorac Soc 2004; 1: 4-9.
19. Vallet V, Chrai B, Gaeggeler HP, et al. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature 1997; 389 (6651): 607-610.
20. Seshadri S, Lin DC, Rosati M, et al. Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis. Allergy 2012; 67: 920-928